USC/Norris Comprehensive Cancer Center
USC/Norris
About USC/Norris
Patient Care
Research
Clinical Trials
Search Trials
Faculty
Education
Future at USC/Norris
Core Facilities
Support USC/Norris
» Contact Us
» Glossary
» Make a Donation
If you are a patient, please contact
The Doctors of USC
at 800-USC-CARE.
Details for trial 3L-08-1
Description:
A Phase I, Open-Label, Multi-Center, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of GC33, a Recombinant Humanized Antibody to Glypican-3 Administered Weekly in Patients with Advanced or Metastatic Hepatocellular Carcinoma (HCC).
Status:
Open
Randomized?
No
Researchers
Principal Investigator
Title
Heinz Josef Lenz
M.D.
Data Management
Name
Title
Susan Edwards
R.N.
Xiomara Menendez
R.N.
San Aye
D.M.
Yordy Brito
D.M.
Carol Jones
R.N.
You may participate in this study if:
(No criteria found)
You may not participate in this study if:
(No criteria found)
For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.
